Treatment experience of cytomegalovirus infection in pediatric kidney transplant patients
10.3760/cma.j.cn421203-20220610-00136
- VernacularTitle:儿童肾移植术后巨细胞病毒感染9例诊治经验
- Author:
Weijie LI
1
;
Zhiliang GUO
;
Tianhui PAN
;
Daqiang ZHAO
;
Gang CHEN
;
Yu ZHANG
;
Lan ZHU
Author Information
1. 华中科技大学同济医学院附属同济医院药学部，武汉 430030
- Keywords:
Kidney transplantation;
Cytomegalovirus infection;
Children
- From:
Chinese Journal of Organ Transplantation
2022;43(10):598-602
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To summarize the clinical characteristics and treatment of cytomegalovirus(CMV)infection in pediatric kidney transplant patients.Methods:From May 2014 to July 2021, a total of 9 cases(8.65%)of 104 pediatric kidney transplant recipients were diagnosed with CMV infection in our centre.Retrospective data was collected for these 9 paediatric recipients.The clinical characteristics of the disease, treatment data and outcomes were summarized.Results:The median age of the 9 children was 10 years(0.25-15 years), 6 of whom were treated with polyclonal antibody for immunity induction.CMV IgG was negative in 4 children before renal transplantation.Only one patient received anti-CMV prophylaxis.The median time from transplant to the diagnosis of CMV infection was 22(7-15)days.Among the 9 children, 7 had fever, pneumonia and diarrhea, 2 had no typical symptoms, three patients were complicated with viral, bacterial or fungal infections.Acute rejection occurred in 3 patients at the same time as CMV infection or after CMV DNA turned negative.Nine patients were cured and discharged after ganciclovir or valganciclovir treatment.Median time of CMV DNA negative transformation was 32(17-90)days.Conclusions:Pediatric transplant recipients are at particularly elevated risk of CMV disease.Antiviral prophylaxis should be initiated early after transplantation.
